Advertisement

Advertisement

Departments

Advertisement

Advertisement



Apr
23
Today In Oncology
Does Intake of Dietary Fat Increase Risk of Skin Cancer?
FDA Approves Pembrolizumab Plus Axitinib for First-Line Treatment of Advanced Renal Cell Carcinoma
Cervical Cancer Subtype Rising in Some Populations
Deep-Learning Model May Improve Predictions of Survival and Specific Outcomes in Lung Cancer
KEYNOTE-042: Pembrolizumab vs Chemotherapy in Previously Untreated Locally Advanced or Metastatic NSCLC With PD-L1 Expression ≥ 1%
View More 
;
Advertisement
Most Read Stories
Report Examines Shortages of Oncologists, Variation in Cancer Rates
Primary Surgery Outcomes in MRI-Based ‘Good-Prognosis’ Rectal Cancer
Addition of Radiotherapy After Breast-Conserving Surgery Based on Level of Tumor-Infiltrating Lymphocytes
Addition of Bortezomib to R-CHOP in DLBCL Subtypes Identified With Gene-Expression Profiling
KEYNOTE-158: Pembrolizumab in Previously Treated Advanced Cervical Cancer
View More 
Most Viewed Videos
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
Wells A. Messersmith, MD, on Managing Metastatic Colorectal Cancer: NCCN Guidelines Update
Heinz-Josef Lenz, MD, on Pancreatic Cancer Tumor Profiling and Treatment Response: Results From the COMPASS Trial
Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes
Rana R. McKay, MD, on Renal Cell Carcinoma: Results From a Trial on Atezolizumab and Bevacizumab
View More 
© 2019 HSP News Service, L.L.C.